Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Asset Resilience Ratio

Latest as of March 2026: 0.00%

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares asset resilience ratio. Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hong Kong Pharma Digital Technology Hold (HKPD) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$12.84 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2024–2026)

Asset resilience ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2024 to 2026. This chart shows how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Asset Resilience Ratio has changed over time. Read Hong Kong Pharma Digital Technology Hold (HKPD) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hong Kong Pharma Digital Technology Hold asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Industry Peers by Asset Resilience Ratio

Compare Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hanmi Science
KO:008930
Medical Distribution 0.04%
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
Medical Distribution 1.77%
ShareHope Medicine Co Ltd
TWO:8403
Medical Distribution 3.61%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Asset Resilience Ratio by Year (2024–2026)

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares asset resilience ratio by year from 2024 to 2026. The table below shows the annual Asset Resilience Ratio data for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 0.00% $0.00 $12.84 Million --
2025-03-31 23.96% $2.26 Million $9.42 Million --
2024-03-31 0.00% $0.00 $8.67 Million --
pp = percentage points

About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

NASDAQ:HKPD USA Medical Distribution
Market Cap
$77.17 Million
Market Cap Rank
#28168 Global
#5805 in USA
Share Price
$1.83
Change (1 day)
-7.58%
52-Week Range
$0.10 - $2.19
All Time High
$2.80
About

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides valu… Read more